Pharmacovigilance, and COVID-19

Filali, Houda; Kadil, Youness

All published articles of this journal are available on ScienceDirect.

LETTER TO THE EDITOR

Pharmacovigilance, and COVID-19

Houda Filali¹ Youness Kadil^{, *} ^{, 1} Authors Info & Affiliations

The Open COVID Journal • 16 Mar 2021 • LETTER TO THE EDITOR • DOI: 10.2174/2666958702101010020

Fulltext HTML PDF ePub

Authors & Information

Authors

Affiliations

Houda Filali ¹

Youness Kadil ^{, *}¹

Information

Published In

The Open COVID Journal

LETTER TO THE EDITOR

Article Information

Year: 2021

Volume: 1

E-location ID: TOCOVIDJ-1-20

DOI: 10.2174/2666958702101010020

Cite As

Filali H, Kadil Y. Pharmacovigilance, and COVID-19. Open Covid J, 2021; 1: . http://dx.doi.org/10.2174/2666958702101010020

Article History

Received Date: 11 Dec 2020

Revision Received Date: 21 Jan 2021

Electronic Publication Date: 16 Mar 2021

Copyright

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ACKNOWLEDGEMENTS

Declared none.

Download

Download1

Download

Fulltext PDF ePub

Citations & Metrics

Citations

Cite As

Filali H, Kadil Y. Pharmacovigilance, and COVID-19. Open Covid J, 2021; 1: . http://dx.doi.org/10.2174/2666958702101010020

Export Citation

Select the format you want to export the citation of this publication.

Metrics

Article Usage (Last 30 Days)

Article Usage (Demographic)

Copyright & License

Open-Access License: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Address correspondence to this author at Faculty of Medicine and Pharmacy of Casablanca, Laboratory of Pharmacology-Toxicology, Hassan II University of Casabalnca, Casablanca 2000, Morocco; E-mail: younesskadil@gmail.com

Pharmacovigilance, and COVID-19

Follow Us

Authors & Information

Authors

Affiliations

Information

Published In

Article Information

Cite As

Article History

Copyright

ACKNOWLEDGEMENTS

Download

Download1

Download

Citations & Metrics

Citations

Cite As

Export Citation

Metrics

Article Usage (Last 30 Days)

Article Usage (Demographic)

Copyright & License

Copyright & License

© 2021 Filali and Kadil.

Media

Figures

Tables

Authors

Affiliations

Information

Published In

Article Information

Cite As

Article History

Copyright

ACKNOWLEDGEMENTS

Download1

Download

Citations

Cite As

Export Citation

Metrics

Article Usage (Last 30 Days)

Article Usage (Demographic)

Copyright & License

© 2021 Filali and Kadil.

Figures

Share

Share article link

Share on social media